JP2022506109A5 - - Google Patents
Info
- Publication number
- JP2022506109A5 JP2022506109A5 JP2021523277A JP2021523277A JP2022506109A5 JP 2022506109 A5 JP2022506109 A5 JP 2022506109A5 JP 2021523277 A JP2021523277 A JP 2021523277A JP 2021523277 A JP2021523277 A JP 2021523277A JP 2022506109 A5 JP2022506109 A5 JP 2022506109A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862752510P | 2018-10-30 | 2018-10-30 | |
| US62/752,510 | 2018-10-30 | ||
| PCT/US2019/058898 WO2020092594A1 (en) | 2018-10-30 | 2019-10-30 | Therapeutic compounds and compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022506109A JP2022506109A (ja) | 2022-01-17 |
| JPWO2020092594A5 JPWO2020092594A5 (https=) | 2022-10-28 |
| JP2022506109A5 true JP2022506109A5 (https=) | 2022-10-28 |
Family
ID=70464743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523277A Pending JP2022506109A (ja) | 2018-10-30 | 2019-10-30 | 治療用化合物および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210253550A1 (https=) |
| EP (1) | EP3873446A4 (https=) |
| JP (1) | JP2022506109A (https=) |
| KR (1) | KR20210084581A (https=) |
| CN (1) | CN113056263A (https=) |
| AU (1) | AU2019369518A1 (https=) |
| BR (1) | BR112021008462A2 (https=) |
| CA (1) | CA3117549A1 (https=) |
| IL (1) | IL282765A (https=) |
| WO (1) | WO2020092594A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2733405C2 (ru) | 2014-02-07 | 2020-10-01 | Экзитера Фармасьютикалз Инк. | Терапевтические соединения и композиции |
| EP3749662A4 (en) | 2018-02-07 | 2021-07-14 | Exithera Pharmaceuticals Inc. | THERAPEUTIC COMPOUNDS AND COMPOSITIONS |
| TW202345825A (zh) * | 2022-03-30 | 2023-12-01 | 大陸商四川海思科製藥有限公司 | 環狀內醯胺類化合物的注射用藥物組合物及其製備方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| US5760246A (en) | 1996-12-17 | 1998-06-02 | Biller; Scott A. | Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method |
| GB0205527D0 (en) | 2002-03-08 | 2002-04-24 | Ferring Bv | Inhibitors |
| CA2648522A1 (en) * | 2005-04-04 | 2006-10-12 | Daiamed, Inc. | Substituted azetidinones |
| KR101937514B1 (ko) * | 2011-10-14 | 2019-01-10 | 브리스톨-마이어스 스큅 컴퍼니 | 인자 xia 억제제로서의 치환된 테트라히드로이소퀴놀린 화합물 |
| RU2733405C2 (ru) * | 2014-02-07 | 2020-10-01 | Экзитера Фармасьютикалз Инк. | Терапевтические соединения и композиции |
| US20190315711A1 (en) * | 2016-12-23 | 2019-10-17 | Exithera Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| WO2020092592A1 (en) * | 2018-10-30 | 2020-05-07 | Exithera Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
| EP3917910A4 (en) * | 2019-01-29 | 2022-11-09 | Exithera Pharmaceuticals Inc. | THERAPEUTIC COMPOUNDS AND COMPOSITIONS |
-
2019
- 2019-10-30 KR KR1020217016347A patent/KR20210084581A/ko not_active Withdrawn
- 2019-10-30 AU AU2019369518A patent/AU2019369518A1/en not_active Abandoned
- 2019-10-30 BR BR112021008462-2A patent/BR112021008462A2/pt unknown
- 2019-10-30 EP EP19880599.6A patent/EP3873446A4/en active Pending
- 2019-10-30 CN CN201980072155.7A patent/CN113056263A/zh active Pending
- 2019-10-30 JP JP2021523277A patent/JP2022506109A/ja active Pending
- 2019-10-30 WO PCT/US2019/058898 patent/WO2020092594A1/en not_active Ceased
- 2019-10-30 CA CA3117549A patent/CA3117549A1/en active Pending
-
2021
- 2021-04-28 IL IL282765A patent/IL282765A/en unknown
- 2021-04-30 US US17/245,691 patent/US20210253550A1/en not_active Abandoned